Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES 9. Verify Nomination in Account, click on link (:: Central Depository Services (India) Limited :: )
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Customer Guest
Login | Register
Login | Register|Forgot password?
The company reported standalone net profit during the quarter stood at Rs 1.10 crore compared to net loss of Rs 1.94 crore in the previous year quart...more...
Audited Results 31.03.2026more...
Audited Financial Results for the quarter and year ended 31st March 2026more...
ANG Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia t...more...
As of March 2026 70.60% is owned by Indian Promoters and 29.40% by Public. Top two Promoters holding highest number of shares of ANG Lifesciences Ind...more...
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company ANG Life...more...
Certificate under Reg 74(5) of SEBI (DP) Regulations 2018more...
This is with reference to the email communication received from BSE Limited on April 09 2026 seeking clarification for a significant movemen...more...
The Exchange has sought clarification from ANG Lifesciences India Ltd on April 9 2026 with reference to significant movement in price in order to ens...more...
As of December 2025 70.60% is owned by Indian Promoters and 29.40% by Public. Top two Promoters holding highest number of shares of ANG Life...more...
The company reported standalone net loss during the quarter stood at Rs 4.24 crore as compared to net loss of Rs 4.57 crore in the previous year quar...more...
Unaudited Financial Results 31.12.2025.more...
Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended 31-12-2025more...
ANG Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 inter alia t...more...
Disclosure under Reg. 74(5) of SEBI (DP) Regulations 2018.more...
BOARD MEETINGS Company Name : Majestic Research Date : 30-06-2026